| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Oxeladin | Oxeladin EP Impurity A | VE000108 | View CAS 140-82-9 |
Oxeladin Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Oxeladin | Oxeladin EP Impurity A | VE000108 | View CAS 140-82-9 |
| Catalogue No. | VE000108 |
| CAS No. | 140-82-9 |
| Molecular Formula | C8H19NO2 |
| Molecular Weight | 161.24 g/mol |
| Parent drug | Oxeladin |
| IUPAC Name | 2-[2-(Diethylamino)ethoxy]ethanol |
| Synonyms | Butamirate Inhouse Impurity A |
| References | Morice, A., & Kardos, P. (2016). Comprehensive evidence-based review on European antitussives. BMJ Open Respiratory Research, 3(1), e000137. https://doi.org/10.1136/bmjresp-2016-000137 |
| Status | In-stock |
| ListName | Oxeladin EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
